Viva Biotech Holdings (VB0) — Cash Flow Quality Index
Viva Biotech Holdings (VB0) has a Cash Flow Quality Index of 313.38x as of June 2023. Operating cash flow of €158.72 Million exceeds net income of €506.50K, indicating high earnings quality where cash backs reported profits. Explore how well can Viva Biotech Holdings service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Viva Biotech Holdings Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Viva Biotech Holdings across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see VB0 cash flow metrics.
Annual Cash Flow Quality Index for Viva Biotech Holdings (2016–2024)
Year-by-year earnings quality comparison for Viva Biotech Holdings.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | €373.99 Million | €167.29 Million | ▲ +725.9% |
| 2021 | 0.27x | €77.83 Million | €287.55 Million | ▲ +56.4% |
| 2019 | 0.17x | €46.01 Million | €265.90 Million | ▲ +29.4% |
| 2018 | 0.13x | €12.11 Million | €90.55 Million | ▼ -63.4% |
| 2017 | 0.37x | €27.89 Million | €76.26 Million | ▼ -57.6% |
| 2016 | 0.86x | €21.12 Million | €24.47 Million | — |